Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07604675 · ClinicalTrials.gov registry record · NA
Patient Agreement Form and Medication Abortion Knowledge
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 637
- Enrollment target
NCT07604675 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 637 participants.
The verdict
NCT07604675, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 637 participants
- Enrollment target
Study Summary
This study evaluates whether exposure to the U.S. Food and Drug Administration (FDA)-required Patient Agreement Form (PAF) for mifepristone improves patient knowledge about medication abortion. Participants seeking medication abortion at clinical sites in the United States were randomized to complete a knowledge assessment either before or after reviewing and signing the PAF. The primary objective was to assess whether exposure to the PAF improves knowledge related to medication abortion, including medication use, effectiveness, risks, and when to seek medical care.
Interventions
- BEHAVIORAL Patient Agreement Form (PAF)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 637 participants |
| Start Date | 2025-01-15 |
| Est. Completion | 2025-10-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07604675
The ClinicalTrials.gov registry entry for NCT07604675 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 637 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Patient Agreement Form (PAF) is the first listed.
NCT07604675 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07604675 about?
NCT07604675 is a clinical study titled "Patient Agreement Form and Medication Abortion Knowledge". This study evaluates whether exposure to the U.S. Food and Drug Administration (FDA)-required Patient Agreement Form (PAF) for mifepristone improves patient knowledge about medication abortion. Participants seeking medication abortion at clinical sites in the United States were randomized to complet...
What is the current status of trial NCT07604675?
This trial is currently completed. It is a NA study. The enrollment target is 637 participants. The study started on 2025-01-15. Estimated completion is 2025-10-17.
What interventions are being tested in trial NCT07604675?
The interventions under investigation include: Patient Agreement Form (PAF) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07604675?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.